Godavari Biorefineries schedules board meeting on Aug 5 to approve Q2 2026 unaudited results

What Godavari Biorefineries announced

Godavari Biorefineries Ltd (BSE: 544279) informed the Bombay Stock Exchange that its Board of Directors will meet on 5 August 2026. The agenda includes the consideration and approval of the unaudited financial results for the quarter ended 30 June 2026. The notice was filed on 21 July 2026.

"The meeting of the Board of Directors of the Company is scheduled on 05/08/2026, inter alia, to consider and approve Un‑Audited Financial Results for the quarter ended on June 30, 2026."

No quantitative data—such as revenue, profit, or cash flow figures—were disclosed in the filing.

Board meeting details

• Date of meeting: 5 August 2026
• Purpose: Review and approve the unaudited financial statements for Q2 FY2026 (quarter ended 30 June 2026).
• Filing date: 21 July 2026, submitted to BSE.
• Ticker: 544279 (BSE). The company does not have a listed NSE ticker at the time of this filing.

The board’s approval of unaudited results is a standard procedural step. Once approved, the company will typically proceed to finalise the audited statements, which are then released to shareholders and the market.

Un‑audited financial results – what is known?

The filing does not contain any financial numbers. It merely signals that the board will examine the unaudited statements prepared by management. The unaudited results are expected to cover:

• Sales and revenue generated during the quarter.
• Operating expenses and EBITDA.
• Net profit or loss before tax.
• Cash flow from operating activities.
• Any material events or transactions that occurred in the quarter.

Because the figures are unaudited, they are subject to verification by the company’s auditors before the final audited results are published.

Key facts at a glance

Why this matters for investors

The announcement is primarily procedural. It confirms that the company is on schedule to finalise its quarterly reporting cycle. Investors should note that:

• No financial performance data is available yet; any assessment of the quarter’s results must wait for the subsequent earnings release.
• The board’s approval of unaudited results does not imply any change in the company’s financial position; it simply validates the numbers prepared by management.
• Once the audited results are released, they may affect key ratios, dividend considerations, and future capital allocation decisions.
• The timing of the board meeting (early August) suggests that the audited results could be disclosed later in August or early September, following standard regulatory timelines.

Conclusion

Godavari Biorefineries has scheduled its board meeting for 5 August 2026 to approve the unaudited financial results for the quarter ended 30 June 2026. The filing does not provide any financial figures, and investors will need to await the audited results for substantive performance insight. The procedural nature of the notice indicates normal compliance with reporting requirements.